Informing Decisions in Chronic Critical Illness: A Randomized Control Trial (RCT)

October 28, 2015 updated by: Icahn School of Medicine at Mount Sinai
The purpose of this study is to test a communication intervention to support family decision-making for patients with chronic critical illness.

Study Overview

Detailed Description

Increasing use of intensive care therapies by an aging population has created a new medical syndrome - "chronic critical illness" - encompassing multi-system derangements, recurrent complications, and protracted/permanent dependence on mechanical ventilation and other life-supports. Numbering >100,000 at any point in time, the chronically critically ill are a growing population of older adults and a serious national health problem. Annual expenditures for these patients are estimated at $24 billion, mostly for patients ≥ 65 years old. Yet 6-month mortality rates exceed those for most malignancies, impairments are severe among survivors, and return to the community is rare. Descriptive research has identified domains of information that are important for decision-making by patients/families about continuation of treatment in the chronic phase of critical illness, but has also revealed that decisions are often made without this information or patient goals of care as a context. In acute critical illness, scheduled, structured meetings and printed informational aids are effective for Intensive Care Unit (ICU) families, but no study has tested an intervention to inform and support decision-making about chronic critical illness. This study is a randomized, controlled, multi-center clinical trial of such an intervention. Specific Aims are: (1) To evaluate the impact on family- and patient-focused outcomes of a proactive program of protocolized, interdisciplinary, informational support meetings led by a palliative care physician, plus a printed informational aid, for families of chronically critically ill patients; and (2) To evaluate the impact of this intervention on utilization of critical care resources for the chronically critically ill. We hypothesize that as compared to usual care plus the printed aid, this intervention will effectively inform decision-making, improve family well-being, promote discussion of preferences for patient goals of care, and optimize critical care resource utilization, without increasing patient mortality.

Study Type

Interventional

Enrollment (Actual)

622

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10029
        • Icahn School of Medicine at Mount Sinai
    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • University of North Carolina School of Medicine
      • Durham, North Carolina, United States, 27710
        • Duke University School of Medicine
      • Durham, North Carolina, United States, 27704
        • Durham Regional Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mechanically ventilated ≥ 7 days
  • Mechanically ventilated without > 96 hour interruption
  • Age ≥ 21 years
  • ICU MD does not expect patient will die within 72 hours
  • ICU MD does not expect patient will be liberated from the ventilator within 72 hours.

Exclusion Criteria:

  • Previous admission to study ICU this hospitalization Mechanically ventilated at outside hospital for > 7 days before transfer
  • Chronic Neuromuscular (NM) Disease
  • Trauma
  • Burn
  • Previous palliative care consultation in this hospitalization
  • No family or other surrogate decision-maker
  • Family not available
  • Surrogate lacks English proficiency
  • Physician refused permission for research staff to approach the family

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care Group
Experimental: Supportive Information Team Group
Protocolized information and support meetings led by palliative care clinicians
A minimum of two protocolized, interdisciplinary, informational support meetings led by palliative care clinicians will be arranged with family members or other patient surrogates who participate in decision-making for individual chronically critically ill patients.
Other Names:
  • SIT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Hospital Anxiety and Depression Scale
Time Frame: Day 90
Day 90

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: Day 90
Day 90
Hospital Anxiety and Depression Scale
Time Frame: Day 18-20
Day 18-20
Impact of Events Scale-Revised
Time Frame: Day 90
Day 90
Discussion of Preferences for Patients Goals of Care
Time Frame: Day 18-20
Subscale of Center for Gerontology and Health Care Research Toolkit
Day 18-20
Quality of Communication
Time Frame: Day 18-20
Curtis Measure
Day 18-20
Family Satisfaction in the Intensive Care Unit (ICU) Survey
Time Frame: Day 90
Day 90
Modified Center for Gerontology and Health Care Research (CHCR) Tool
Time Frame: Day 90
Day 90
Limitation of Intensive Care Unit (ICU) Therapy
Time Frame: Average of 60 days
Percent of patients with mechanical ventilation, renal replacement, vasopressors, or artificial nutrition withheld or withdrawn
Average of 60 days
Hospital Length of Stay
Time Frame: Average of 60 days
Days since randomization
Average of 60 days
Physician-Surrogate Discordance Score
Time Frame: day 18-20
day 18-20
Discussion of Preferences for Patients Goals of Care
Time Frame: Day 90
Subscale of Center for Gerontology and Health Care Research Toolkit
Day 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Judith Nelson, MD, JD, Icahn School of Medicine at Mount Sinai

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2010

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

October 22, 2010

First Submitted That Met QC Criteria

October 27, 2010

First Posted (Estimate)

October 28, 2010

Study Record Updates

Last Update Posted (Estimate)

October 29, 2015

Last Update Submitted That Met QC Criteria

October 28, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 08-0601 0001 01 ME
  • R01NR012413-01A1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Critical Illness

Clinical Trials on Supportive Information Team Group

3
Subscribe